Aim: Studies have shown that eye movement abnormalities are possible neurophysiological biomarkers for schizophrenia. The aim of this study was to investigate the utility of eye movement abnormalities in identifying patients with schizophrenia from healthy controls.
measures as neurophysiological biomarkers have been conducted, showing specific findings in schizophrenia compared to mood disorders. 3, 4 There are also studies that use multiple eye movement measures to classify patients with schizophrenia and healthy controls, resulting in a discriminative accuracy of 80-90%. [5] [6] [7] These studies have shown that by using multiple eye movement measures, it is possible to increase the classification accuracy. However, only a handful of the many eye movement measures are useful in distinguishing schizophrenia, and the effects of the other factors confounding this classification have not been studied in depth. In the current study, we aimed to identify the eye movement measures that best characterize schizophrenia and create an integrated score to distinguish patients with schizophrenia from healthy controls. We also examined the effect of demographic confounders with individual eye movement measures to further understand the significance of the eye movement score created.
METHODS

Subjects
Eye movements were recorded from 85 patients with schizophrenia and 252 healthy controls, recruited at Osaka University. All subjects were biologically unrelated, were of Japanese descent, and had no history of ophthalmologic disease, or neurological/ medical conditions that could influence the central nervous system. 8, 9 Specific exclusion criteria included atypical headaches, head trauma with loss of consciousness, chronic lung disease, kidney disease, chronic hepatic disease, thyroid disease, active cancer, cerebrovascular disease, epilepsy, seizures, substance-related disorders, or mental retardation. Healthy controls were recruited through regional advertisements at Osaka University and were evaluated for psychiatric, medical, and neurological concerns using the non-patient version of the SCID to exclude individuals with current or past contact with psychiatric services or who had received psychiatric medication. Patients with schizophrenia were recruited from Osaka University Hospital and had been diagnosed by two or more trained psychiatrists according to criteria from the DSM-IV based on the Structured Clinical Interview for DSM-IV (SCID). Current symptoms of schizophrenia were evaluated using the Positive and Negative Syndrome Scale (PANSS) 10 and the total of prescribed antipsychotics was calculated using chlorpromazine (CPZ) equivalents (mg/day). 11 Current IQ was measured using the Japanese version of the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). 12 Premorbid IQ was estimated using the Japanese version of the National Adult Reading Test. 13 The demographic information of the subjects is shown in Table 1 .
The study was performed in accordance with the World Medical Association's Declaration of Helsinki and was approved by the Research Ethical Committee of Osaka University. All participants provided written consent to the study after full explanation of the study procedures. Anonymity was preserved for all participants.
Eye movement recordings and processing of eye movement data
The subjects faced a 19-in. liquid crystal display monitor placed at 70 cm distance from the observers' eyes. Visual stimuli were presented using MATLAB (The Mathworks, Natick, MA, USA) via the Psychophysics Toolbox extension. 14 The eye movements and pupil areas of the left eye were measured at 1 kHz using the EyeLink1000 (SR Research, Ontario, Canada) system.
Eye position data were smoothed with a digital FIR filter (−3 dB at 30 Hz), and the eye velocity and acceleration traces were obtained using the twopoint forward difference algorithm to identify saccadic eye movements. Eye movement records were next segmented into the blink, the saccade, and the fixation periods. First, we identified the blink periods where data were missing. Periods of high-speed deflections of the eye positions were next identified as candidates of saccade periods (eye velocity > 35 / s, eye acceleration >5000 /s 2 ). However, high-speed deflections that followed or were followed by the blink periods (within 50 ms) and high-speed deflections that were accompanied by changes in the pupil area (>25 units/samples) were likely to be artifacts associated with eyelid closures during the blinks, so these periods were incorporated into the corresponding blink periods. The periods that involved small positional noise could sometimes be captured, due to the low detection threshold of the previously described saccade criteria. To avoid inclusions of these to saccade periods, the periods with too small deflections (0.1 ), too short/long duration (<10 ms or >300 ms), or too high accelerations (AE0.6 × 105) were eliminated from the list of candidates for saccades, and the other high-speed deflection periods were identified as the saccade periods. Finally, the remaining periods were identified as fixation periods if the periods were longer than 20 ms; if the periods were shorter than 20 ms, they were considered as unidentified periods. The saccades moving toward/from outside of the screen and fixations outside the screen were marked and excluded when the eye movement measures were calculated.
Eye movement paradigms and measures extracted
We administered three eye movement examinations in seven paradigms and obtained a total of 75 eye movement measures. Standard eye movement examinations used in previous published reports were chosen. [5] [6] [7] Examples of eye movement examination are given in Figure 1 . Each paradigm is discussed in detail below.
The free viewing test was performed using images from eight categories that involved natural environments, buildings, everyday items, foods, faces, animals, fractal patterns, and noise (seven images for each category); the images of natural environments and animals were selected from the International Affective Pictures System, 15 and the images of the faces were selected from Matsumoto and Ekman. 16 The subjects were instructed to freely view the presented image for a period of 8 s (Fig. 1a) . We measured the number and the median duration of the fixations, the number of saccades, the median durations, the amplitude, the average and the peak velocity of saccades, the scanpath length, and the fixation density. 17 The medians over each image were calculated for each eye movement measure. Additionally, we examined the main sequence relation of the saccades of individual subjects by fitting the function V = a × {1 − exp. (−b × A)} + c to the amplitude (A) and the peak eye velocity (V) of the saccades obtained from all trials, where a, b and c were optimized.
In the smooth pursuit eye movement test, subjects were required to track a moving target for 20 s. The target moved horizontally with a sinusoidal trajectory (horizontal pursuit paradigm), or it moved both horizontally and vertically with Lissajous trajectories of different frequencies (slow and fast Lissajous paradigms; Fig. 1b) . Each trial was repeated twice. We measured the number and the median duration of fixations, along with the number, median duration, amplitude, average, and peak velocities of saccades. Additionally, we measured the position gain, the velocity gain, the common logarithm of the signal-to-noise ratio (SNR) and the root mean square error (RMSE) for the horizontal and the vertical eye movements separately in each trial.
For the fixation stability test, subjects were required to maintain their gaze on a fixation target presented at the center of the monitor (Fig. 1c) . A few seconds after the central fixation target was presented, a distracter stimulus appeared at either 1.5 (near distractor) or 3.0 (far distractor) of the center fixation target. In one paradigm, no distractor stimulus appeared. We measured the number of fixations, the median duration of fixations, the number of saccades, the number of microsaccades and the scanpath length for each trial. We averaged each eye movement measure over trials for each of the no, near, and far distracter paradigms.
Statistical analysis
All statistical analyses were performed using SPSS 23.0 (IBM Corp., Armonk, NY, USA). Group comparisons of demographic variables were performed using a two-tailed t-test or a χ 2 -test when appropriate. The differences between eye movement measures in patients with schizophrenia and healthy controls were assessed using an independent t-test, and the effect sizes were determined by Cohen's d.
To create an integrative measure that represents the eye movement abnormalities of schizophrenia, a canonical discriminant analysis with a stepwise procedure was applied. The inclusion and exclusion of variables in this stepwise algorithm were performed using the Mahalanobis distance; the maximum significance of the F-value to enter was 0.05; the minimum significance of the F-value to remove was 0.1. Discriminant power was also assessed using receiver-operator curve (ROC) analysis. Pearson's correlations were used to examine the relations among age, sex, years of education, PANSS scores, CPZ equivalents, and the eye movement score as well as individual eye movement measures that were used to calculate the integrated score. The significance level was set at P < 0.05.
RESULTS
Demographics and eye movement measures
The demographics of both groups are shown in Table 1 . There was no difference in the sex ratio between the two groups (P = 0.215); however, age, years of education, premorbid IQ, and current IQ differed significantly (P = 2.41 × 10 , respectively). A total of 75 eye movement measures were obtained in this study (Table S1 ). These include 13 measures from the free viewing test, 44 measures from the smooth pursuit test (12 for the horizontal pursuit paradigm and 16 for both Lissajous pursuit paradigms), and 18 measures were extracted from the fixation stability test (six from each of the three paradigms). The measures with the largest group differences specified by Bonferroni corrected P-values (raw P-values multiplied by 75) are shown in Table 2 . These were: the scanpath length for the free viewing test (P = 1.25 × 10 −25
, d = 1.5); the horizontal position gain for the horizontal pursuit paradigm, slow Lissajous paradigm, and fast Lissajous paradigm of the smooth pursuit test , d = 1.2, respectively); and the duration of fixations for the no distractor paradigm, near distractor paradigm, and far distractor paradigm of the fixation stability test (P = 3.82 × 10 
Discriminant analysis
An integrated eye movement score was created using a canonical discriminant analysis. Eye movement measures with greater differences between healthy controls and patients with schizophrenia (i.e., smaller P-values) would be of most use in the classification, thus the seven eye movement measures described above were chosen as possible candidates for creating the integrated eye movement score. The stepwise canonical discriminant analysis reduced the seven measures to three, which were the scanpath length from the free viewing test, the horizontal position gain from the fast Lissajous paradigm of the smooth pursuit test, and the duration of fixations from the far distractor paradigm of the fixation stability test.
The resulting discriminant function (y) was expressed as follows: The distribution of the integrated eye movement score was well separated between the patients with schizophrenia and healthy controls (Fig. 2) , with an effect size of 2.0. In the discriminant analysis, the eye movement score correctly classified 82.5% of the subjects in the re-substitution method, and correctly classified 81.9% of the subjects in the leaveone-out cross-validation method. The sensitivity and specificity of the score were 0.79 and 0.84, respectively. The ROC is shown in Figure 3 , with an area under the ROC of 0.89 (95% confidence interval: 0.85-0.93).
Correlation analysis
Correlations between the eye movement score, individual eye movement measures used in the score, demographic characteristics, and clinical characteristics were also assessed. As for demographic characteristics, correlations with current IQ were seen in the integrated score in both groups, and among current IQ, horizontal position gain, and scanpath length in patients with schizophrenia (0.1 < R < 0.4, raw P < 0.05). There were also weak correlations observed between age and duration of fixations in both healthy controls and patients with schizophrenia (R = −0.14, raw P = 2.65 × 10 −2 and R = −0.26, raw P = 1.71 × 10 −2 , respectively). No correlations were seen with the other demographics. After correcting for multiple comparisons using Bonferroni correction by multiplying the raw P-values by 40, no correlations remained significant (Table 3) . Between the three eye movement measures used in the score, the scanpath length and the horizontal position gain (R = −0.24, raw P = 2.89 × 10 −2 ) were weakly correlated in patients with schizophrenia; however, this effect did not remain after correcting for multiple comparison by multiplying the raw P-values by 12 (Table 3) . For clinical features of the patients with schizophrenia, moderate correlations were observed with total CPZ equivalent of prescribed antipsychotics in the integrated score (R = −0.41, corrected P = 2.92 × 10 ), which were significant after Bonferroni correction, multiplying the raw P-values by 36. Weak correlation was seen between the integrated score and the total CPZ equivalent of prescribed atypical antipsychotics (R = −0.35, corrected P = 4.31 × 10
−2
). Other clinical factors also showed weak correlations, which were not significant after multiple correction (Table 4) . 
Demographic matched group analysis
To investigate the effect of these demographic factors on the discriminative ability of the eye movement score, we extracted 66 patients with schizophrenia and 66 healthy controls matched in age, sex, years of education, and premorbid IQ from the original dataset (for demographics, see Table 5) . These subjects were then re-classified using the eye movement score. The eye movement score correctly classified 79.5% of the subjects in the matched dataset with a sensitivity and specificity of 0.77 and 0.82, respectively.
DISCUSSION
In this study, we established an integrated eye movement score to distinguish patients with schizophrenia from healthy controls. Only eye movement measures with large differences between groups were selected, and the integrated score, although using only three eye movement measures, was able to distinguish patients with schizophrenia from healthy controls with 82% accuracy. The eye movement score also showed a correlation with clinical features, notably the amount of prescribed antipsychotics.
One key feature of our integrated eye movement score is the use of three basic and easily obtained eye movement measures. The classification rate in our study is slightly lower than in previous studies. [5] [6] [7] These studies have used different methods -for example, the adoption of machine learning techniques 6 -to enhance the discrimination rate. However, the use of more dimensions may be prone to overfitting the original dataset, 18 and the integrated measures may cease to represent schizophrenia pathology in general. Arolt et al. 5 only used three measures, one of which was decreased gain during smooth pursuit. Although they integrated more measures, Benson et al. 6 and Miura et al. 7 also used a decreased scanpath length, a decreased gain during smooth pursuit, and a reduced duration of fixations during fixation stability tests in their measures, which may indicate the pathologic relevance of these three eye movement abnormalities.
The correlation between prescribed antipsychotics and the integrated score was of moderate strength and was significant after correcting for multiple comparisons. This may be an important confounder in our results. A study by Miura et al., 7 in which approximately half of the data overlap with the current study, also mentions this finding. In individual eye movement measures, this effect was particularly seen in the horizontal position gain during smooth pursuit. There have been many studies on the effect of antipsychotics on smooth pursuit, and the results vary. A recently published multisite study reported no significant association between smooth pursuit measures and antipsychotic use. 4 Studies on antipsychotic-naïve patients with schizophrenia have also shown smooth pursuit abnormalities before treatment initiation as well. [19] [20] [21] [22] However, these studies have also shown that smooth pursuit abnormalities progress after antipsychotic initiation. This effect has been associated with a longer duration of treatment. 21, 22 Thus, the disease severity of the patients with schizophrenia who were enrolled in this study may have led to this finding.
In addition, we observed negative correlations between age and duration of fixations in both subject groups. Although the correlations were weak and were not significant after correcting for multiple comparisons, there still may be need for consideration as a confounding factor. Correlations between fixation stability and age in healthy controls have also been pointed out by Benson et al. 6 In some studies that used anti-saccade paradigms, more incorrect pro-saccadic movements have been reported in association with older age. 23, 24 This voluntary inhibition of automatic saccades to a distractor stimulus may be related to our findings. Our analysis in demographically matched subgroups revealed similar classification rates; however, there still may be a need for age correction in further studies when using fixation measures. Several limitations must be considered. There is a possibility of further enhancing the classification rate of our integrated eye movement score by using machine learning techniques, although there may be drawbacks, as previously described. The use of other eye movement tasks, such as anti-saccade tasks, which have been known to be impaired in patients with schizophrenia, may also improve our results. Demographic confounders, especially medication and current IQ, still need to be accounted for. Both eye movement abnormalities and cognitive decline 25 have been identified in schizophrenia, and further analysis on the relation of these two factors is needed. We also need to validate our findings of correlation in larger datasets because results obtained after correcting for multiple comparisons may be too conservative. The use of more diverse data, such as multisite data, may also be useful. In addition, studies on other psychiatric illnesses, such as mood disorders, would be needed to conclude that these eye movement abnormalities are specific to schizophrenia pathology.
In conclusion, we have created an integrated eye movement score that discriminates patients with schizophrenia from healthy controls with more than 80% accuracy. This was maintained even after correcting for demographic differences between the two groups. Our score consisted of only three out of 75 eye movement measures that were originally obtained, and it may be possible to further decrease the time required to fulfill the test. Methodological simplicity and short examination time are crucial in clinical settings; thus, our results imply the utility of integrated eye movement measures as a possible candidate biomarker of schizophrenia.
